Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-006505

Options or other derivatives

  • Chief Financial Officer acquired 538,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Moran Sean F. · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-02-01 Grant or award : show line 1 in the form Stock Option (right to buy) +538,400 $0.47 2032-02-01 538,400 538,400 D
Loading xslF345X03/doc4.xml…